Colon Cell Differentiation: NAB and MUC2 Gene Expression

结肠细胞分化:NAB 和 MUC2 基因表达

基本信息

  • 批准号:
    7384462
  • 负责人:
  • 金额:
    $ 22.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-04-15 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The short chain fatty acid butyrate (NaB), present in high concentrations in the colonic lumen principally from the fermentation of dietary fiber, plays a physiological role in colonic homeostasis. This involves maintaining an equilibrium not only between cell proliferation in the lower section of the crypt and cell loss at the top of the crypt, but also a balance among the multiple cell lineages in the mucosa. However, butyrate effects are complex, in that butyrate induces differentiation in vitro, but promotes growth in vivo. This complexity is further emphasized by our findings demonstrating that NaB specifically represses that expression of the MUC2 gene, which encodes the major colonic mucin, and does so by inhibiting HDAC activity (Oncogene, in press). It is our hypothesis that the intestine has developed specific mechanisms to respond to natural compounds, such as NaB, present in the lumen to modulate cell differentiation as a function of cell position along the crypt axis. Alterations in this balance may increase the probability of tumor formation. Utilizing cell systems that recapitulate the goblet and ion transporter phenotypes, and molecular reagents developed in the lab, we will define the molecular determinants in cell lineage specific differentiation that can be regulated by NaB by determining: 1. Whether there are NaB responsive elements in the promoter of the human and mouse MUC2 genes. 2. Whether HDAC activity can counteract NaB mediated repression of MUC2 3. Whether there is modulation of SP1/SP3 activity, which we demonstrated is important for MUC2 regulation. 4. Whether post-translational modifications of SP1/SP3 may bring about loss of transcriptional activity. This will be done in vitro using standard immunological and molecular biology techniques. We will expand these studies in vivo, and determine, by CHIP analysis, if the chromatin structure of the gene is important for MUC2 expression. In addition, we will determine the dynamic occupancy of SP1/SP3 at functionally relevant sites, and the transcription factors and co-factors that may participate in the formation of multiprotein complexes upon interaction with SP1 and SP3 as a function of MUC2 repression. 5. Finally, we will extend our use of microarray technology to determine how NaB perturbs profiles of gene expression that define lineage specific differentiation (Velcich et al., submitted).
描述(由申请人提供):短链脂肪酸丁酸盐(NaB)主要通过膳食纤维的发酵高浓度存在于结肠腔中,在结肠内稳态中起生理作用。这不仅需要维持隐窝下部的细胞增殖和隐窝顶部的细胞损失之间的平衡,还需要维持粘膜中多个细胞系之间的平衡。然而,丁酸盐的作用是复杂的,因为丁酸盐在体外诱导分化,但在体内促进生长。我们的研究结果进一步强调了这种复杂性,表明NaB通过抑制HDAC活性特异性地抑制MUC2基因的表达,MUC2基因编码主要的结肠粘蛋白(Oncogene, in press)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANNA VELCICH其他文献

ANNA VELCICH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANNA VELCICH', 18)}}的其他基金

Colon Cell Differentiation: NAB and MUC2 Gene Expression
结肠细胞分化:NAB 和 MUC2 基因表达
  • 批准号:
    7921237
  • 财政年份:
    2009
  • 资助金额:
    $ 22.39万
  • 项目类别:
Colon Cell Differentiation: NAB and MUC2 Gene Expression
结肠细胞分化:NAB 和 MUC2 基因表达
  • 批准号:
    7031044
  • 财政年份:
    2004
  • 资助金额:
    $ 22.39万
  • 项目类别:
Colon Cell Differentiation: NAB and MUC2 Gene Expression
结肠细胞分化:NAB 和 MUC2 基因表达
  • 批准号:
    7216205
  • 财政年份:
    2004
  • 资助金额:
    $ 22.39万
  • 项目类别:
Colon Cell Differentiation: NAB and MUC2 Gene Expression
结肠细胞分化:NAB 和 MUC2 基因表达
  • 批准号:
    6881065
  • 财政年份:
    2004
  • 资助金额:
    $ 22.39万
  • 项目类别:
Colon Cell Differentiation: NAB and MUC2 Gene Expression
结肠细胞分化:NAB 和 MUC2 基因表达
  • 批准号:
    6778616
  • 财政年份:
    2004
  • 资助金额:
    $ 22.39万
  • 项目类别:
Inactivation of the Muc2 gene and colorectal cancer
Muc2 基因失活与结直肠癌
  • 批准号:
    6871338
  • 财政年份:
    2001
  • 资助金额:
    $ 22.39万
  • 项目类别:
Inactivation of the Muc2 gene and colorectal cancer
Muc2 基因失活与结直肠癌
  • 批准号:
    6323750
  • 财政年份:
    2001
  • 资助金额:
    $ 22.39万
  • 项目类别:
Inactivation of the Muc2 gene and colorectal cancer
Muc2 基因失活与结直肠癌
  • 批准号:
    6515013
  • 财政年份:
    2001
  • 资助金额:
    $ 22.39万
  • 项目类别:
Inactivation of the Muc2 gene and colorectal cancer
Muc2 基因失活与结直肠癌
  • 批准号:
    6721259
  • 财政年份:
    2001
  • 资助金额:
    $ 22.39万
  • 项目类别:
Inactivation of the Muc2 gene and colorectal cancer
Muc2 基因失活与结直肠癌
  • 批准号:
    6634020
  • 财政年份:
    2001
  • 资助金额:
    $ 22.39万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 22.39万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 22.39万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.39万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了